AzddMeC is primarily utilized in the field of antiviral research, particularly in the study of nucleoside analogs. It serves as a modified nucleoside that can be incorporated into viral RNA or DNA, potentially inhibiting viral replication. This compound is of significant interest in the development of treatments for viral infections, as it may interfere with the viral polymerase enzyme, disrupting the synthesis of viral genetic material. Researchers explore its efficacy against a range of viruses, aiming to design more effective antiviral therapies. Its application extends to both in vitro studies and preclinical trials, where its mechanism of action and safety profile are evaluated.